LyGenesis and Imagine Pharma Announce Joint Research Collaboration to Develop Novel Cell Therapies for Patients with Type 1 Diabetes

LyGenesis, Inc. and Imagine Pharma , a biotechnology company focused on the development of its novel polypeptide (IMG-1) across three distinct platforms.

Scroll to Top